Visudyne verteporfin 15mg injection

Get a Price/Quote

Visudyne verteporfin 15mg injection Specification

Pacakaging (Quantity Per Box)
1 vial per box

Indication
Choroidal neovascularization, mainly secondary to age-related macular degeneration

Life Span
Check expiration date on package; typically ranges from 18 to 24 months from manufacturing

Salt Composition
Verteporfin 15 mg

Dosage Form
Lyophilized powder for solution for injection

Origin of Medicine
Imported/Pharmaceutical (Manufactured by Novartis)

Packaging Type
Glass vial with carton packaging

Drug Type
Prescription drug

Ingredients
Visudyne (verteporfin) 15 mg is a light-activated prescription injection used with non-thermal laser therapy to treat abnormal, leaking blood vessels in the eye Treats wet age-related macular degeneration (AMD) with classic subfoveal choroidal neovascularization.Treats subfoveal choroidal neovascularization caused by pathological myopia or ocular histoplasmosis.Works as a photosensitizer that accumulates in new eye blood vessels and is activated by a specific laser wavelength to destroy abnormal tissue without harming surrounding retina layers

Physical Form
Liquid

Function
Photosensitizer used in photodynamic therapy

Recommended For
Treatment of predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia, or presumed ocular histoplasmosis

Dosage
15 mg per vial; to be reconstituted for intravenous use as per prescribing information

Dosage Guidelines
Administer as directed by a physician experienced in the management of ophthalmic conditions. Not intended for self-administration.

Suitable For
Adults

Quantity
15 mg per vial

Storage Instructions
Store at 2C to 8C (Refrigerate, do not freeze). Protect from light.

Preparation Instructions
Requires reconstitution prior to administration

ATC Code
S01LA01

Market Availability
Available in select pharmacies and hospitals for use under specialist supervision

Caution
Avoid exposure of skin and eyes to direct sunlight or bright indoor light for 48 hours post-injection

Adverse Effects
Injection site reactions, visual disturbances, photosensitivity reactions

Administration Route
Intravenous (IV)

Light Protection
Product must be protected from light during storage and after reconstitution

Prescription Category
Schedule H (Rx only)

Photodynamic Therapy Use
Used in conjunction with nonthermal laser light

Pharmaceutical Form
Sterile lyophilized powder in a vial

Reconstitution Solvent
Sterile 5% dextrose solution or as directed in the package insert

Shelf Life
2 years from the date of manufacture (always verify on label)

Contraindications
Known hypersensitivity to verteporfin or excipients; porphyria

About Visudyne verteporfin 15mg injection

Visudyne (verteporfin) 15 mg injection is a gilt-edged pharmaceutical formulated as a sterile lyophilized powder for intravenous use following reconstitution with sterile 5% dextrose solution. This immaculate, light-activated photosensitizer is highlighted for its unprecedented efficacy in treating choroidal neovascularization associated with wet age-related macular degeneration, pathological myopia, and ocular histoplasmosis. Access to this treatment is restricted to select pharmacies and hospitals under specialist supervision. Its reduced adverse event profile, coupled with rigorous quality control, ensures both efficacy and safety for eligible adults. Protection from light is essential throughout storage and handling.

Where Visudyne Verteporfin 15mg Injection Is Used and Key Advantages

Visudyne is prominently utilized in premium ophthalmological centers and specialized hospitals, administered by qualified healthcare professionals. It is mainly used by ophthalmologists skilled in managing complex retinal disorders. Among its primary competitive advantages are targeted action with minimal damage to surrounding tissue, reduced recovery times, and proven efficacy in managing choroidal neovascularization. Its advanced formulation and specialist-only administration ensure a gilt-edged therapeutic approach for patients seeking innovative ocular care.

Payment, Delivery, and Packaging Details for Visudyne Verteporfin 15mg

Purchase of Visudyne verteporfin 15mg injection ensures premium quality at the lowest price through authorized distributors. Products are delivered safely and promptly, observing strict temperature and light protection requirements during transit. Each vial is securely packed in a glass container inside a protective carton, typically one vial per box, preserving its immaculate condition. Standard payment terms apply upon procurement, guaranteeing both efficiency and authenticity in every transaction.

FAQ's of Visudyne verteporfin 15mg injection:

Q: How should Visudyne verteporfin 15mg injection be administered?

A: Visudyne must be reconstituted with sterile 5% dextrose solution and given as an intravenous injection by a healthcare professional, followed by activation using nonthermal laser light.

Q: What conditions does Visudyne verteporfin 15mg treat?

A: Visudyne is indicated for the treatment of predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathological myopia, or ocular histoplasmosis.

Q: Where can I access Visudyne verteporfin 15mg treatment?

A: Visudyne is accessible in select pharmacies and hospitals under specialist supervision and is not available for over-the-counter purchase.

Q: When should light exposure be avoided after receiving Visudyne?

A: You must avoid exposure of skin and eyes to direct sunlight or bright indoor light for at least 48 hours following the injection to prevent photosensitivity reactions.

Q: What benefits distinguish Visudyne verteporfin from other treatments?

A: Visudyne provides targeted destruction of abnormal blood vessels while sparing surrounding retinal tissue, resulting in reduced risk of collateral damage and potentially better visual outcomes.

Tell us about your requirement